Skip to content

A randomised double-blind study to compare two regimens of Levonorgestrel in emergency contraception in Nigeria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN69287540
Enrollment
3150
Registered
2004-04-01
Start date
2002-08-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception Pregnancy and Childbirth Contraception

Interventions

1. Levonorgestrel two doses of 0.75 mg 12 hours apart 2. Levonorgestrel one dose of 1.5 mg

Sponsors

World Health Organization (WHO) (Switzerland)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Requesting emergency contraception within 120 hours of unprotected intercourse 2. Only one act of unprotected intercourse during current cycle 3. Willing to abstain from further acts during current cycle 4. Regular menstrual cycles (24 to 42 days) 5. Having at least one spontaneous cycle before current cycle 6. Available for follow-up in the next six weeks 7. Negative pregnancy test 8. Willing to participate 9. Not breastfeeding 10. No use of hormonal contraceptives or of rhythm or natural family planning method of contraception during current cycle 11. Not unsure about the date of last menstrual period

Exclusion criteria

Exclusion criteria: Does not comply with the above inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Efficacy, side-effects and timing of next menstrual period at six weeks.

Secondary

MeasureTime frame
No secondary outcome measures

Countries

Nigeria

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026